Cresco Labs (CRLBF) Assets Average (2021 - 2026)
Cresco Labs' (CRLBF) quarterly Assets Average came in at $1.2 billion in Q1 2026, down 11.89% YoY from $1.4 billion in Q1 2025, and down 3.29% on a QoQ basis from $1.2 billion in Q4 2025.
Cresco Labs (CRLBF) Assets Average (2021 - 2026) Analysis & Trends
Cresco Labs (CRLBF) has 6 years of Assets Average data on file, last reported at $1.2 billion in Q1 2026.
- Quarterly Assets Average fell 11.89% year-over-year to $1.2 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.2 billion (down 11.89% YoY) and the FY2025 annual result came in at $1.3 billion, down 5.94% from the prior year.
- Assets Average declined to $1.2 billion in Q1 2026, from $1.2 billion in the prior quarter.
- In the past five years, Assets Average ranged from a high of $1.8 billion in Q1 2022 to a low of $1.2 billion in Q1 2026.
- A 5-year average of $1.5 billion and a median of $1.4 billion in 2024 frame the typical range for Assets Average.
- Annual changes were most pronounced in 2023 — Assets Average retreated 17.44% — and 2025, when it grew 0.03%.
- Tracing CRLBF's Assets Average over 5 years: stood at $1.7 billion in 2022, then declined by 17.44% to $1.4 billion in 2023, then declined by 0.7% to $1.4 billion in 2024, then decreased by 9.52% to $1.2 billion in 2025, then fell by 3.29% to $1.2 billion in 2026.
- The last three Assets Average figures came in at $1.2 billion (Q1 2026), $1.2 billion (Q4 2025), and $1.3 billion (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | 43.72 Bn |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 39.95 Bn |
| 3 | Zoetis | 31.53 Bn | 29.85 Bn | 1.05 Bn | 15.12 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 98.59 Bn |
| 5 | United Therapeutics | 22.13 Bn | 19.47 Bn | 683.80 Mn | 6.97 Bn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 35.94 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 5.13 Bn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 13.39 Bn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | 5.97 Bn |
| 10 | Cresco Labs | 292.94 Mn | 228.83 Mn | 86.95 Mn | 1.23 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.20 Bn |
| Dec 31, 2025 | 1.24 Bn |
| Sep 30, 2025 | 1.31 Bn |
| Jun 30, 2025 | 1.36 Bn |
| Mar 31, 2025 | 1.36 Bn |
| Dec 31, 2024 | 1.37 Bn |
| Sep 30, 2024 | 1.37 Bn |
| Jun 30, 2024 | 1.36 Bn |
| Mar 31, 2024 | 1.36 Bn |
| Dec 31, 2023 | 1.38 Bn |
| Sep 30, 2023 | 1.46 Bn |
| Jun 30, 2023 | 1.53 Bn |
| Mar 31, 2023 | 1.57 Bn |
| Dec 31, 2022 | 1.67 Bn |
| Sep 30, 2022 | 1.73 Bn |
| Jun 30, 2022 | 1.74 Bn |
| Mar 31, 2022 | 1.78 Bn |
| Dec 31, 2021 | 1.68 Bn |